Meghmani Organics Limited (MOL) AI Stock Analysis

• Market Cap: ₹15.27B
• Dividend Yield: N/A
• Average Volume (3M): 53.48K
• Price to Earnings (P/E): 38.6
• Beta (1Y): 1.40
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IN
• Employees: 1,720
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 0.46
• Shares Outstanding: 254,314,210
• 10 Day Avg. Volume: 52,595
• 30 Day Avg. Volume: 53,476
• PEG Ratio: 1.75
• Price to Book (P/B): 1.10
• Price to Sales (P/S): 0.78
• P/FCF Ratio: -73.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 330.77
• Revenue Forecast (FY): ₹2.31T

• Rating: 45 Neutral
• Price Target: ₹70.00 ▲(8.04% Upside)

The overall stock score is primarily influenced by the company's weak financial performance and bearish technical indicators. The high P/E ratio without a dividend yield further detracts from its valuation appeal. The lack of earnings call and corporate events data leaves these areas unaddressed.

Positive Factors

Business Model Strength

MOL's diversified product portfolio across multiple sectors enhances its resilience and ability to capitalize on various market opportunities.

Strategic Partnerships

Strategic partnerships and long-term contracts provide stable revenue streams and enhance market reach, supporting sustained growth.

Sustainable Product Demand

Rising demand for eco-friendly chemicals aligns with global sustainability trends, positioning MOL for long-term growth in emerging markets.

Negative Factors

Declining Revenue

Declining revenue trends can undermine long-term growth prospects and market competitiveness, necessitating strategic adjustments.

Negative Cash Flow

Negative free cash flow indicates potential liquidity issues, limiting the company's ability to invest in growth without external financing.

High Leverage

High leverage increases financial risk and can strain cash flow, impacting the company's ability to navigate economic downturns.

Meghmani Organics Limited Business Overview & Revenue Model

Company Description

Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. It offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. The company also provides agrochemical products comprises insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil; herbicides, such as triclopyr butoxy ethyl ester, as well as 2,4-D acid tech, sodium salt WP/SP, and EsterTech; intermediates, including cypermethric acid chloride, meta phenoxy benzaldehyde, meta phenoxy benzyl alcohol, monochloroacetic acid, high trans cypermethric acid chloride, and high cis cypermethric acid chloride; and technical and formulations that are used in crop protection, veterinary, public health, and wood protection applications. Meghmani Organics Limited was founded in 1986 and is based in Ahmedabad, India.

How the Company Makes Money

Meghmani Organics generates revenue through the production and sale of its core products, which include agrochemicals and pigments. The company's revenue model is primarily based on direct sales to distributors, wholesalers, and manufacturers in both domestic and international markets. Key revenue streams stem from the agrochemical sector, where it leverages its research and development capabilities to create effective crop protection solutions. Additionally, the company benefits from long-term contracts and strategic partnerships with agricultural firms and industrial manufacturers, enhancing its market reach and stability. The global demand for sustainable and eco-friendly chemicals also contributes positively to its earnings, allowing MOL to capitalize on emerging market trends.

Meghmani Organics Limited Financial Statement Overview

Summary

Meghmani Organics Limited is facing financial challenges characterized by declining revenues, negative net income, and high leverage. While there are some improvements in operational margins, the overall financial health is strained by negative cash flows and profitability inefficiencies.

Income Statement

The company displays declining revenue with negative growth in the recent year. Gross and net profit margins have been volatile, with the latest year showing a negative net income, impacting the overall profitability. While the EBIT margin has improved, EBITDA margin remains relatively low, indicating potential operational inefficiencies.

Balance Sheet

The balance sheet shows a high debt-to-equity ratio, suggesting increased leverage and potential financial risk. The equity ratio is moderate, reflecting a balanced asset financing structure. Return on equity has been negative recently, indicating challenges in generating shareholder value.

Cash Flow

The cash flow statement reveals negative free cash flow over the past years, signaling potential liquidity issues. The operating cash flow is insufficient to cover capital expenditures, affecting the company's ability to fund operations without external financing. The free cash flow to net income ratio highlights a disconnect between profitability and cash generation.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	22.79B	21.24B	15.48B	25.28B	24.73B	16.12B
Gross Profit	9.00B	8.60B	5.21B	4.79B	10.01B	6.93B
EBITDA	2.34B	1.87B	119.50M	4.10B	4.81B	3.11B
Net Income	188.41M	-106.01M	-1.06B	2.38B	3.04B	1.86B
Balance Sheet
Total Assets	0.00	30.85B	30.40B	31.98B	27.98B	19.74B
Cash, Cash Equivalents and Short-Term Investments	226.82M	227.24M	330.74M	1.52B	117.22M	1.23B
Total Debt	0.00	8.29B	8.37B	8.24B	4.99B	2.68B
Total Liabilities	-15.15B	15.70B	15.12B	15.29B	13.31B	8.01B
Stockholders Equity	15.15B	15.15B	15.28B	16.69B	14.66B	11.73B
Cash Flow
Free Cash Flow	0.00	-226.88M	-165.29M	-2.61B	-1.79B	1.24B
Operating Cash Flow	0.00	662.22M	2.50B	2.04B	648.32M	3.33B
Investing Cash Flow	0.00	309.70M	-1.78B	-4.18B	-1.33B	-3.07B
Financing Cash Flow	0.00	-913.88M	-854.77M	2.34B	577.19M	-142.40M

Meghmani Organics Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 64.79
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Negative. The current price of 64.79 is above the 20-day moving average (MA) of 63.17, below the 50-day MA of 67.17, and below the 200-day MA of 79.61, indicating a bearish trend. The MACD of -1.63 indicates Positive momentum. The RSI at 31.29 is Neutral, neither overbought nor oversold. The STOCH value of 11.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FCL	75 Outperform	₹26.65B	27.17	―	0.65%	-10.12%	-22.38%
TATVA	64 Neutral	₹29.76B	167.79	―	0.07%	16.88%	0.69%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
IOLCP	60 Neutral	₹23.02B	19.87	―	0.97%	5.74%	16.06%
DCW	55 Neutral	₹15.96B	31.93	―	0.16%	0.95%	488.81%
TNPL	55 Neutral	₹9.62B	-47.89	―	2.08%	4.65%	-127.24%
MOL	45 Neutral	₹15.27B	38.62	―	―	―	―

Meghmani Organics Limited Corporate Events

Meghmani Organics Closes Trading Window Ahead of December Quarter Results

Meghmani Organics Limited has announced the closure of its trading window for equity shares from 1 January 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ending 31 December 2025, in line with SEBI’s Prohibition of Insider Trading regulations and the company’s internal code of conduct for insiders. The company has also appointed Central Depository Services Limited to enforce trading restrictions on designated persons and their immediate relatives by freezing PAN at the security level for its specified ISIN, underscoring tightened compliance and governance measures ahead of the forthcoming quarterly results, with the board meeting date for approving these results to be announced later.

Meghmani Organics Schedules Investor Meeting with Seven Canyon Funds

Meghmani Organics Limited has announced a scheduled meeting with Seven Canyon Funds, set to take place on December 2, 2025, in Ahmedabad. This meeting is part of the company’s ongoing engagement with investors and analysts to discuss its operations and strategies, reflecting its commitment to transparency and stakeholder communication.